ICATIBANT ACETATE

ICATIBANT ACETATE was reported 6011 times

ICATIBANT ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COMPLEMENT DEFICIENCY DISEASE 14 0.3784
1 HEREDITARY ANGIOEDEMA 2634 0.2452
2 ALLERGY TO STING 2 0.1667
3 VASCULAR ACCESS SITE COMPLICATION 26 0.1032
4 COMPLEMENT FACTOR ABNORMAL 5 0.0467
5 GASTRIC DYSPLASIA 2 0.0426
6 LARYNGEAL DISORDER 20 0.0277
7 LARYNGEAL OEDEMA 132 0.0214
8 RESPIRATORY TRACT OEDEMA 13 0.0175
9 PHARYNGEAL SWELLING 165 0.0168
10 INADVERTENT INJECTION AIR BUBBLE 2 0.0159
11 CATHETER SITE VESICLES 3 0.0154
12 ENZYME LEVEL DECREASED 2 0.0152
13 GENITAL DISORDER 2 0.0149
14 DEATH OF RELATIVE 6 0.0148
15 DRUG TITRATION 2 0.0128
16 INFECTIVE GLOSSITIS 2 0.0128
17 CENTRAL VENOUS CATHETER REMOVAL 6 0.0128
18 FACIAL DISCOMFORT 9 0.0127
19 BODY HEIGHT INCREASED 6 0.0122
20 INSURANCE ISSUE 179 0.0117
21 GENITAL SWELLING 8 0.0116
22 OESOPHAGEAL OEDEMA 3 0.0106
23 EXPOSURE TO EXTREME TEMPERATURE 2 0.0103
24 ADMINISTRATION SITE PAIN 11 0.0095
25 LIP INFECTION 2 0.0094
26 EXPOSURE TO FUNGUS 2 0.0093
27 ALLERGY TO PLANTS 4 0.0088
28 SYNOVIAL RUPTURE 3 0.0087
29 NONSPECIFIC REACTION 46 0.0084
30 PHARYNGEAL OEDEMA 128 0.0083
31 INCISION SITE DISCHARGE 2 0.0079
32 VEIN COLLAPSE 6 0.0078
33 RETINAL VASCULAR THROMBOSIS 4 0.0076
34 DUMPING SYNDROME 2 0.0076
35 PRESCRIBED OVERDOSE 146 0.0075
36 POOR VENOUS ACCESS 77 0.0074
37 THERAPY REGIMEN CHANGED 3 0.0074
38 MIXED CONNECTIVE TISSUE DISEASE 3 0.0071
39 EXCESSIVE SKIN 2 0.0071
40 STRESS AT WORK 8 0.0071
41 ADMINISTRATION SITE ERYTHEMA 2 0.0070
42 LENS DISORDER 2 0.0069
43 LOCALISED OEDEMA 31 0.0067
44 INCISION SITE SWELLING 2 0.0066
45 PRODUCT DISTRIBUTION ISSUE 61 0.0066
46 ALLERGY TO VACCINE 2 0.0065
47 ALLERGY TO ARTHROPOD BITE 2 0.0063
48 ABDOMINAL SYMPTOM 5 0.0062
49 VASCULAR ACCESS COMPLICATION 5 0.0062
50 ABDOMINOPLASTY 2 0.0060
51 CATHETER SITE IRRITATION 2 0.0060
52 IODINE ALLERGY 2 0.0060
53 CENTRAL VENOUS CATHETERISATION 18 0.0060
54 PRODUCT RECONSTITUTION QUALITY ISSUE 5 0.0056
55 INFUSION SITE BRUISING 12 0.0056
56 MICTURITION FREQUENCY DECREASED 4 0.0053
57 TRACHEITIS 4 0.0052
58 CAROTID BRUIT 2 0.0052
59 WEIGHT FLUCTUATION 54 0.0052
60 BREAST FEEDING 4 0.0051
61 BLOOD OESTROGEN INCREASED 3 0.0051
62 LUNG CYST 2 0.0051
63 CATHETER SITE EXTRAVASATION 2 0.0050
64 INFUSION SITE URTICARIA 3 0.0045
65 ENLARGED UVULA 2 0.0045
66 VEIN RUPTURE 7 0.0042
67 INTESTINAL ANGIOEDEMA 2 0.0042
68 ANIMAL BITE 11 0.0041
69 INFUSION SITE PRURITUS 13 0.0041
70 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
71 BLISTER RUPTURE 3 0.0040
72 CARDIAC INFECTION 3 0.0040
73 VULVOVAGINAL SWELLING 7 0.0038
74 DENTAL CARE 7 0.0038
75 VASCULAR DEVICE INFECTION 17 0.0037
76 STRIDOR 11 0.0037
77 DEVICE RELATED INFECTION 57 0.0037
78 PANCREATITIS RELAPSING 3 0.0037
79 POST PROCEDURAL SWELLING 4 0.0036
80 INCISION SITE COMPLICATION 3 0.0036
81 CRANIOFACIAL FRACTURE 3 0.0035
82 ELECTRIC SHOCK 3 0.0035
83 TRACHEOSTOMY 5 0.0035
84 PHARYNGEAL DISORDER 10 0.0035
85 ACUTE ABDOMEN 5 0.0034
86 CHEST INJURY 7 0.0034
87 OOPHORECTOMY 3 0.0034
88 ENDOSCOPY 2 0.0033
89 ALLERGY TO METALS 2 0.0033
90 PRODUCT AVAILABILITY ISSUE 75 0.0033
91 BONE CONTUSION 3 0.0033
92 HAEMOCHROMATOSIS 3 0.0032
93 BIOPSY 3 0.0032
94 ALLERGY TO CHEMICALS 4 0.0032
95 MONOCLONAL GAMMOPATHY 2 0.0032
96 VASCULAR PAIN 3 0.0031
97 CONCUSSION 24 0.0031
98 MITE ALLERGY 2 0.0031
99 DELIVERY 2 0.0030
100 ARTHROPOD STING 5 0.0030
101 FOOD ALLERGY 23 0.0030
102 SWOLLEN TONGUE 92 0.0029
103 CATHETER SITE INFECTION 11 0.0029
104 INFUSION SITE DISCOMFORT 3 0.0029
105 ALLERGY TO ANIMAL 3 0.0028
106 JUGULAR VEIN THROMBOSIS 5 0.0028
107 MULTIPLE ALLERGIES 22 0.0028
108 VEIN DISORDER 14 0.0028
109 IMMUNISATION REACTION 2 0.0028
110 MOUTH SWELLING 16 0.0028
111 BITE 2 0.0028
112 INJECTION SITE IRRITATION 35 0.0027
113 INFUSION SITE PAIN 35 0.0027
114 TONSILLAR DISORDER 3 0.0027
115 LIMB CRUSHING INJURY 2 0.0027
116 COMPLICATION OF PREGNANCY 2 0.0026
117 GASTROINTESTINAL BACTERIAL INFECTION 3 0.0026
118 SPLENECTOMY 3 0.0026
119 NECK SURGERY 6 0.0026
120 DRUG TOLERANCE INCREASED 2 0.0026
121 CROUP INFECTIOUS 2 0.0025
122 WEIGHT ABNORMAL 6 0.0025
123 MATERNAL EXPOSURE DURING BREAST FEEDING 10 0.0025
124 INJECTION SITE SCAR 7 0.0025
125 HAEMATOLOGICAL INFECTION 6 0.0025
126 INFUSION SITE WARMTH 3 0.0024
127 PRODUCT PREPARATION ISSUE 16 0.0024
128 DENTAL OPERATION 6 0.0024
129 DRUG EFFECT DELAYED 11 0.0024
130 COVID-19 IMMUNISATION 2 0.0024
131 INFUSION SITE OEDEMA 2 0.0024
132 INFUSION SITE ERYTHEMA 20 0.0024
133 FRACTURED COCCYX 3 0.0024
134 TYMPANIC MEMBRANE PERFORATION 4 0.0024
135 SPLEEN DISORDER 4 0.0024
136 EAR SWELLING 5 0.0024
137 ENDOCRINE DISORDER 3 0.0023
138 THERAPY CHANGE 23 0.0023
139 INFUSION SITE IRRITATION 3 0.0023
140 TREATMENT DELAYED 4 0.0023
141 CATHETER SITE PAIN 6 0.0023
142 ENDOMETRIOSIS 11 0.0023
143 CYSTOCELE 2 0.0023
144 ACCIDENT AT WORK 5 0.0023
145 PRODUCT DOSE OMISSION IN ERROR 64 0.0023
146 INABILITY TO AFFORD MEDICATION 22 0.0022
147 CATHETER SITE SWELLING 2 0.0021
148 ORAL SURGERY 5 0.0021
149 INTUSSUSCEPTION 2 0.0021
150 DEVICE RELATED THROMBOSIS 2 0.0020
151 BRAIN HYPOXIA 2 0.0020
152 AGE-RELATED MACULAR DEGENERATION 3 0.0020
153 RUBBER SENSITIVITY 3 0.0020
154 INJECTION SITE PARAESTHESIA 3 0.0020
155 BLADDER DYSFUNCTION 2 0.0019
156 FOREIGN BODY IN THROAT 6 0.0019
157 OROPHARYNGEAL DISCOMFORT 17 0.0019
158 DEVICE INEFFECTIVE 2 0.0019
159 BONE NEOPLASM 2 0.0019
160 TONGUE OEDEMA 7 0.0018
161 INFUSION SITE HAEMORRHAGE 6 0.0018
162 COLONOSCOPY 4 0.0018
163 LYME DISEASE 6 0.0018
164 TONGUE DISORDER 13 0.0018
165 FACIAL SPASM 2 0.0018
166 ENDOTRACHEAL INTUBATION 5 0.0018
167 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 11 0.0018
168 METABOLIC SURGERY 2 0.0018
169 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
170 DERMATITIS CONTACT 20 0.0018
171 CENTRAL NERVOUS SYSTEM INFECTION 2 0.0017
172 INJECTION SITE OEDEMA 3 0.0017
173 CHEMICAL BURN 2 0.0017
174 INCISION SITE PAIN 2 0.0017
175 GASTROINTESTINAL OEDEMA 3 0.0017
176 WEIGHT INCREASED 379 0.0017
177 MULTIMORBIDITY 2 0.0017
178 LOCAL SWELLING 29 0.0017
179 SWELLING FACE 108 0.0017
180 EMERGENCY CARE 5 0.0016
181 PREGNANCY 33 0.0016
182 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
183 HORMONE LEVEL ABNORMAL 8 0.0016
184 SEASONAL ALLERGY 23 0.0016
185 INJECTION SITE CELLULITIS 3 0.0016
186 ANEURYSM 8 0.0016
187 INFUSION SITE SWELLING 10 0.0016
188 LIP DISORDER 3 0.0016
189 FACE INJURY 6 0.0016
190 KIDNEY INFECTION 31 0.0016
191 APPENDICITIS PERFORATED 4 0.0016
192 PHARYNGITIS STREPTOCOCCAL 17 0.0016
193 INJECTION SITE URTICARIA 38 0.0015
194 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 11 0.0015
195 NASAL SEPTUM DEVIATION 3 0.0015
196 PRODUCT DOSE OMISSION ISSUE 451 0.0015
197 LIP INJURY 2 0.0015
198 INTENTIONAL PRODUCT USE ISSUE 133 0.0015
199 LIGAMENT SPRAIN 15 0.0015
200 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 26 0.0015
201 SUSPECTED COVID-19 5 0.0015
202 GASTROENTERITIS NOROVIRUS 2 0.0015
203 ORAL DISORDER 11 0.0015
204 FOOD POISONING 8 0.0015
205 ABDOMINAL MASS 4 0.0015
206 DEVICE RELATED SEPSIS 3 0.0015
207 LARYNGOSPASM 4 0.0015
208 WEIGHT DECREASED 415 0.0015
209 ARTHROPOD BITE 11 0.0015
210 CALCULUS BLADDER 2 0.0015
211 PRODUCT USE ISSUE 275 0.0015
212 CHRONIC FATIGUE SYNDROME 2 0.0014
213 MAST CELL ACTIVATION SYNDROME 2 0.0014
214 HANGOVER 5 0.0014
215 SWELLING 133 0.0014
216 PANCREATIC DISORDER 7 0.0014
217 SHOULDER OPERATION 6 0.0014
218 CATHETER SITE ERYTHEMA 3 0.0014
219 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 99 0.0014
220 SKIN LACERATION 15 0.0014
221 NECK INJURY 4 0.0014
222 PRODUCT TEMPERATURE EXCURSION ISSUE 7 0.0014
223 LIMB INJURY 37 0.0014
224 CLOSTRIDIUM TEST POSITIVE 3 0.0014
225 ABDOMINAL DISTENSION 142 0.0014
226 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
227 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 243 0.0013
228 ROAD TRAFFIC ACCIDENT 56 0.0013
229 ANGIOEDEMA 59 0.0013
230 INJECTION SITE DISCOMFORT 14 0.0013
231 CRANIOCEREBRAL INJURY 4 0.0013
232 MOUTH INJURY 2 0.0013
233 PERIARTHRITIS 3 0.0013
234 GASTROINTESTINAL DISORDER 118 0.0013
235 ABDOMINAL HERNIA 6 0.0013
236 PROCEDURAL COMPLICATION 10 0.0013
237 EXPIRED PRODUCT ADMINISTERED 43 0.0013
238 INJECTION SITE SWELLING 98 0.0013
239 HYSTERECTOMY 11 0.0013
240 LIP SWELLING 42 0.0013
241 COSTOCHONDRITIS 2 0.0012
242 DERMAL CYST 3 0.0012
243 TOOTH INFECTION 16 0.0012
244 FOOT FRACTURE 23 0.0012
245 FOOT OPERATION 6 0.0012
246 MEDICAL PROCEDURE 2 0.0012
247 POST-TRAUMATIC STRESS DISORDER 8 0.0012
248 INJECTION SITE ERYTHEMA 147 0.0012
249 LIP OEDEMA 5 0.0012
250 MENOPAUSE 3 0.0012
251 ILLNESS 120 0.0012
252 HORDEOLUM 5 0.0012
253 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
254 PRODUCT USE COMPLAINT 18 0.0011
255 INFUSION SITE DISCHARGE 2 0.0011
256 ANAPHYLACTIC REACTION 63 0.0011
257 BLOOD POTASSIUM ABNORMAL 3 0.0011
258 FEAR OF DISEASE 2 0.0011
259 CARDIAC ABLATION 2 0.0011
260 FACIAL BONES FRACTURE 4 0.0011
261 SUSPECTED OFF LABEL USE 5 0.0011
262 LIQUID PRODUCT PHYSICAL ISSUE 8 0.0011
263 NEPHROLITHIASIS 50 0.0011
264 EAR INFECTION 29 0.0011
265 COVID-19 191 0.0011
266 CHOKING SENSATION 6 0.0011
267 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
268 CATHETER PLACEMENT 2 0.0011
269 STREPTOCOCCAL INFECTION 6 0.0011
270 ARTHRITIS INFECTIVE 5 0.0011
271 THERAPY INTERRUPTED 77 0.0011
272 DYSENTERY 2 0.0011
273 THROMBOSIS 86 0.0011
274 OXYGEN SATURATION ABNORMAL 3 0.0011
275 GASTROENTERITIS VIRAL 19 0.0011
276 PRODUCT CONTAINER ISSUE 9 0.0010
277 BREAST MASS 7 0.0010
278 LIMB OPERATION 5 0.0010
279 THERAPEUTIC PRODUCT INEFFECTIVE 4 0.0010
280 JOINT INJURY 22 0.0010
281 CERVIX CARCINOMA 4 0.0010
282 VIRAL INFECTION 34 0.0010
283 SINUSITIS 104 0.0010
284 DIPLEGIA 2 0.0010
285 ACCIDENT 12 0.0010
286 INFUSION SITE REACTION 3 0.0010
287 INJECTION SITE PAIN 307 0.0010
288 UPPER RESPIRATORY TRACT INFECTION 46 0.0010
289 POST PROCEDURAL COMPLICATION 19 0.0010
290 HAND FRACTURE 7 0.0010
291 THERMAL BURN 7 0.0010
292 TOOTH ABSCESS 10 0.0010
293 PRODUCT SUPPLY ISSUE 7 0.0010
294 INJECTION SITE RASH 30 0.0010
295 SYRINGE ISSUE 17 0.0010
296 INJECTION SITE BRUISING 77 0.0010
297 TOOTH EXTRACTION 12 0.0010
298 DEVICE CONNECTION ISSUE 2 0.0009
299 INFLUENZA 105 0.0009
300 HEPATIC PAIN 4 0.0009
301 TOOTH INJURY 4 0.0009
302 BACK INJURY 10 0.0009
303 THROMBOSIS IN DEVICE 3 0.0009
304 LIMB MASS 2 0.0009
305 EXPIRED DEVICE USED 3 0.0009
306 NO ADVERSE EVENT 163 0.0009
307 TOOTH DISORDER 20 0.0009
308 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
309 PLANTAR FASCIITIS 3 0.0009
310 GASTROINTESTINAL INFECTION 8 0.0009
311 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
312 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
313 MENINGITIS ASEPTIC 4 0.0009
314 DIABETIC RETINOPATHY 3 0.0009
315 LUMBAR VERTEBRAL FRACTURE 4 0.0009
316 EYE OPERATION 4 0.0009
317 INFUSION SITE INFECTION 2 0.0009
318 MENOPAUSAL SYMPTOMS 2 0.0009
319 MASS 12 0.0009
320 THROMBOPHLEBITIS 3 0.0009
321 DISCOURAGEMENT 2 0.0009
322 FACIAL PARESIS 3 0.0008
323 CONTRAST MEDIA REACTION 2 0.0008
324 COVID-19 PNEUMONIA 10 0.0008
325 RESPIRATORY TRACT INFECTION 22 0.0008
326 LYMPHOMA 13 0.0008
327 FEAR OF INJECTION 6 0.0008
328 ANKLE FRACTURE 13 0.0008
329 INJECTION SITE REACTION 57 0.0008
330 HERNIA 16 0.0008
331 EXPOSURE DURING PREGNANCY 51 0.0008
332 TOOTH FRACTURE 9 0.0008
333 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
334 BLOOD PRESSURE ABNORMAL 16 0.0008
335 NEEDLE ISSUE 23 0.0008
336 HIP ARTHROPLASTY 12 0.0008
337 HOSPITALISATION 120 0.0008
338 LACTOSE INTOLERANCE 2 0.0008
339 OESOPHAGEAL DISORDER 3 0.0008
340 LIPOMA 2 0.0008
341 RHINOVIRUS INFECTION 3 0.0008
342 HERNIA REPAIR 2 0.0008
343 TONSILLITIS 4 0.0008
344 PNEUMONIA FUNGAL 3 0.0008
345 SENSITIVITY TO WEATHER CHANGE 4 0.0008
346 UPPER LIMB FRACTURE 15 0.0008
347 OBSTRUCTION 3 0.0008
348 ANAESTHETIC COMPLICATION 2 0.0007
349 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
350 URTICARIA 124 0.0007
351 THROAT TIGHTNESS 20 0.0007
352 ABDOMINAL RIGIDITY 2 0.0007
353 PRODUCT PACKAGING ISSUE 7 0.0007
354 MUSCULOSKELETAL DISORDER 14 0.0007
355 LIP BLISTER 2 0.0007
356 APPLICATION SITE HAEMORRHAGE 2 0.0007
357 SPINAL STENOSIS 3 0.0007
358 RESPIRATION ABNORMAL 5 0.0007
359 CYST 9 0.0007
360 CHOLECYSTITIS INFECTIVE 2 0.0007
361 HEART RATE ABNORMAL 4 0.0007
362 APHONIA 10 0.0007
363 HEPATOMEGALY 7 0.0007
364 EYE INFECTION 8 0.0007
365 MUSCLE FATIGUE 3 0.0007
366 ILL-DEFINED DISORDER 43 0.0007
367 BREAST CANCER STAGE IV 2 0.0007
368 BLADDER DISORDER 7 0.0007
369 JOINT LOCK 2 0.0007
370 RESPIRATORY DISORDER 21 0.0007
371 SCAR 12 0.0007
372 OVARIAN CYST 7 0.0007
373 NEUROLOGICAL SYMPTOM 4 0.0007
374 HEART VALVE INCOMPETENCE 2 0.0007
375 MONOPLEGIA 3 0.0007
376 INJECTION SITE HAEMATOMA 10 0.0007
377 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
378 INJECTION SITE WARMTH 14 0.0007
379 UNEVALUABLE EVENT 51 0.0007
380 INJECTION SITE PRURITUS 45 0.0007
381 CARDIAC PACEMAKER INSERTION 4 0.0007
382 MIGRAINE 64 0.0007
383 BLOOD CULTURE POSITIVE 2 0.0007
384 CONDITION AGGRAVATED 203 0.0007
385 INJECTION SITE VESICLES 4 0.0007
386 EYE INJURY 2 0.0007
387 TREATMENT NONCOMPLIANCE 36 0.0007
388 DYSCHEZIA 2 0.0007
389 MASTICATION DISORDER 2 0.0007
390 MATERNAL EXPOSURE DURING PREGNANCY 58 0.0007
391 MENISCUS INJURY 4 0.0006
392 ECTOPIC PREGNANCY 2 0.0006
393 NERVE COMPRESSION 6 0.0006
394 PERIPHERAL SWELLING 100 0.0006
395 FAMILY STRESS 2 0.0006
396 PANCREATITIS 34 0.0006
397 UMBILICAL HERNIA 3 0.0006
398 FEEDING DISORDER 13 0.0006
399 INVESTIGATION 2 0.0006
400 SKIN TIGHTNESS 3 0.0006
401 LEUKAEMIA 6 0.0006
402 SKIN ABRASION 3 0.0006
403 SPINAL DISORDER 6 0.0006
404 HEAD INJURY 20 0.0006
405 MALNUTRITION 7 0.0006
406 LOWER LIMB FRACTURE 12 0.0006
407 CONTUSION 60 0.0006
408 INJECTION SITE MASS 23 0.0006
409 LOCALISED INFECTION 15 0.0006
410 SYSTEMIC LUPUS ERYTHEMATOSUS 22 0.0006
411 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
412 DRUG SPECIFIC ANTIBODY PRESENT 4 0.0006
413 POST PROCEDURAL INFECTION 5 0.0006
414 KNEE OPERATION 6 0.0006
415 INJECTION SITE INFECTION 2 0.0006
416 ESCHERICHIA INFECTION 5 0.0006
417 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
418 IMMUNE SYSTEM DISORDER 8 0.0006
419 ABDOMINAL TENDERNESS 3 0.0006
420 EXPOSURE DURING BREAST FEEDING 2 0.0006
421 EYELID OEDEMA 7 0.0006
422 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33 0.0006
423 ABORTION SPONTANEOUS 24 0.0006
424 EYE SWELLING 22 0.0006
425 HEPATIC CYST 2 0.0006
426 ABDOMINAL PAIN 137 0.0006
427 EAR DISCOMFORT 6 0.0006
428 WRIST FRACTURE 7 0.0006
429 INTESTINAL OBSTRUCTION 22 0.0006
430 RIB FRACTURE 12 0.0006
431 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
432 CARDIAC DISORDER 54 0.0006
433 MALABSORPTION 3 0.0006
434 BRAIN FOG 9 0.0006
435 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
436 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
437 SKIN REACTION 8 0.0006
438 DYSPHONIA 33 0.0006
439 BODY HEIGHT DECREASED 6 0.0006
440 APPENDICECTOMY 2 0.0006
441 FACIAL PAIN 5 0.0006
442 ARTHROPATHY 31 0.0006
443 GINGIVITIS 3 0.0006
444 HEAVY MENSTRUAL BLEEDING 5 0.0006
445 HIP SURGERY 3 0.0006
446 BRAIN OEDEMA 7 0.0006
447 BACK DISORDER 9 0.0006
448 PULMONARY THROMBOSIS 6 0.0005
449 ROTATOR CUFF SYNDROME 7 0.0005
450 BRAIN NEOPLASM 5 0.0005
451 APPENDICITIS 5 0.0005
452 PRODUCT LEAKAGE 3 0.0005
453 CYSTITIS 17 0.0005
454 DYSMENORRHOEA 7 0.0005
455 GENERALISED ERYTHEMA 3 0.0005
456 BRONCHITIS 39 0.0005
457 GASTRIC INFECTION 2 0.0005
458 MUSCLE RUPTURE 2 0.0005
459 IMPAIRED GASTRIC EMPTYING 7 0.0005
460 NASOPHARYNGITIS 94 0.0005
461 THERAPY CESSATION 26 0.0005
462 BLOOD IRON DECREASED 6 0.0005
463 FALL 168 0.0005
464 FURUNCLE 4 0.0005
465 EXPOSURE VIA BREAST MILK 2 0.0005
466 SPINAL FRACTURE 10 0.0005
467 INFUSION RELATED REACTION 33 0.0005
468 RHINITIS 4 0.0005
469 FUNGAL SKIN INFECTION 2 0.0005
470 PRODUCT ADMINISTRATION ERROR 10 0.0005
471 SURGERY 29 0.0005
472 NEOPLASM MALIGNANT 33 0.0005
473 GALLBLADDER OPERATION 2 0.0005
474 TENSION 3 0.0005
475 ANAPHYLACTOID REACTION 2 0.0005
476 INFUSION SITE EXTRAVASATION 3 0.0005
477 SWELLING OF EYELID 3 0.0005
478 AORTIC VALVE INCOMPETENCE 2 0.0005
479 ABSCESS LIMB 2 0.0005
480 FACIAL PARALYSIS 4 0.0005
481 DIVERTICULITIS 13 0.0005
482 INTERVERTEBRAL DISC DISORDER 2 0.0005
483 DRUG EFFECT INCOMPLETE 17 0.0005
484 SEPSIS 52 0.0005
485 MUSCLE STRAIN 4 0.0005
486 PNEUMONIA 149 0.0005
487 PRODUCT PRESCRIBING ISSUE 10 0.0005
488 IMMOBILE 2 0.0005
489 URINARY TRACT INFECTION 78 0.0005
490 MALAISE 200 0.0005
491 INFECTION 66 0.0005
492 GASTROINTESTINAL PAIN 5 0.0005
493 SINUS DISORDER 9 0.0005
494 CORONAVIRUS INFECTION 3 0.0005
495 GINGIVAL SWELLING 2 0.0005
496 LIGAMENT RUPTURE 2 0.0005
497 ABDOMINAL ABSCESS 2 0.0005
498 APPETITE DISORDER 3 0.0005
499 ADVERSE REACTION 6 0.0005
500 NEURALGIA 11 0.0005
501 NERVE INJURY 5 0.0004
502 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
503 GALLBLADDER DISORDER 8 0.0004
504 IMPLANT SITE PAIN 2 0.0004
505 SKIN INFECTION 5 0.0004
506 LOSS OF CONSCIOUSNESS 57 0.0004
507 HEART RATE INCREASED 44 0.0004
508 PANIC ATTACK 16 0.0004
509 HYPERSENSITIVITY 81 0.0004
510 HERPES ZOSTER 25 0.0004
511 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
512 BLOOD POTASSIUM DECREASED 13 0.0004
513 CAESAREAN SECTION 5 0.0004
514 CARPAL TUNNEL SYNDROME 6 0.0004
515 BURNING SENSATION 30 0.0004
516 ANAPHYLACTIC SHOCK 11 0.0004
517 SEIZURE 49 0.0004
518 DEVICE ISSUE 38 0.0004
519 BACTERAEMIA 5 0.0004
520 CATARACT 25 0.0004
521 HYPOVOLAEMIC SHOCK 2 0.0004
522 PANIC REACTION 3 0.0004
523 GUILLAIN-BARRE SYNDROME 2 0.0004
524 ADVERSE EVENT 38 0.0004
525 RASH PUSTULAR 3 0.0004
526 GASTROENTERITIS 6 0.0004
527 AUTOIMMUNE DISORDER 4 0.0004
528 MOUTH HAEMORRHAGE 3 0.0004
529 SENSITIVE SKIN 3 0.0004
530 PSYCHIATRIC SYMPTOM 3 0.0004
531 PULMONARY MASS 6 0.0004
532 INJECTION SITE INFLAMMATION 2 0.0004
533 INJECTION SITE DISCOLOURATION 5 0.0004
534 CHEST PAIN 74 0.0004
535 DEPRESSED MOOD 21 0.0004
536 DEVICE FAILURE 6 0.0004
537 GOUT 7 0.0004
538 ENDOCARDITIS 2 0.0004
539 LIMB DISCOMFORT 12 0.0004
540 APHTHOUS ULCER 3 0.0004
541 HIATUS HERNIA 5 0.0004
542 CRYING 14 0.0004
543 PRODUCT USE IN UNAPPROVED INDICATION 95 0.0004
544 GASTROINTESTINAL INFLAMMATION 3 0.0004
545 DRUG INEFFECTIVE 504 0.0004
546 CYANOSIS 6 0.0004
547 BEDRIDDEN 5 0.0004
548 SCRATCH 4 0.0004
549 SARS-COV-2 TEST POSITIVE 5 0.0004
550 JOINT DISLOCATION 4 0.0004
551 PRODUCT PRESCRIBING ERROR 9 0.0004
552 COMPRESSION FRACTURE 2 0.0004
553 HEADACHE 234 0.0004
554 MALIGNANT MELANOMA 5 0.0004
555 BLOOD PRESSURE INCREASED 57 0.0004
556 STENT PLACEMENT 3 0.0004
557 INJECTION SITE DISCHARGE 2 0.0004
558 POOR QUALITY SLEEP 8 0.0004
559 MYASTHENIA GRAVIS 3 0.0004
560 FRUSTRATION TOLERANCE DECREASED 3 0.0004
561 DRUG EFFECT DECREASED 20 0.0004
562 PRESYNCOPE 9 0.0004
563 COLITIS 14 0.0004
564 GASTRIC ULCER 7 0.0004
565 MENTAL DISORDER 16 0.0004
566 OROPHARYNGEAL PAIN 34 0.0004
567 WOUND INFECTION 4 0.0004
568 JAW DISORDER 2 0.0004
569 FAECALOMA 2 0.0004
570 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
571 STAPHYLOCOCCAL INFECTION 12 0.0004
572 INJECTION SITE NODULE 4 0.0004
573 GLAUCOMA 7 0.0004
574 MENSTRUAL DISORDER 3 0.0004
575 MUSCLE INJURY 3 0.0004
576 VERTIGO 22 0.0004
577 INJECTION SITE INJURY 2 0.0004
578 SYNCOPE 36 0.0004
579 WOUND 10 0.0004
580 GLOSSODYNIA 8 0.0004
581 TYPE 2 DIABETES MELLITUS 12 0.0004
582 FACE OEDEMA 6 0.0004
583 HAEMORRHAGE 37 0.0004
584 CHOLECYSTITIS ACUTE 2 0.0004
585 GASTRIC DISORDER 12 0.0003
586 INFLAMMATION 18 0.0003
587 MUSCULOSKELETAL DISCOMFORT 6 0.0003
588 PARAESTHESIA ORAL 5 0.0003
589 PYELONEPHRITIS 3 0.0003
590 DEVICE DEFECTIVE 6 0.0003
591 HYPOVOLAEMIA 2 0.0003
592 GROIN PAIN 3 0.0003
593 COLD SWEAT 6 0.0003
594 HYPERCHLORHYDRIA 2 0.0003
595 HEAD DISCOMFORT 6 0.0003
596 ENERGY INCREASED 2 0.0003
597 ABDOMINAL PAIN UPPER 69 0.0003
598 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
599 KNEE ARTHROPLASTY 7 0.0003
600 CHEST DISCOMFORT 34 0.0003
601 TOOTHACHE 6 0.0003
602 OSTEOMYELITIS 6 0.0003
603 LOWER RESPIRATORY TRACT INFECTION 15 0.0003
604 URINARY RETENTION 11 0.0003
605 FIBROMYALGIA 8 0.0003
606 INCREASED TENDENCY TO BRUISE 3 0.0003
607 SPINAL OPERATION 4 0.0003
608 TENDONITIS 5 0.0003
609 PHARYNGITIS 4 0.0003
610 DEHYDRATION 43 0.0003
611 LUNG INFECTION 5 0.0003
612 BACTERIAL INFECTION 6 0.0003
613 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
614 OFF LABEL USE 277 0.0003
615 BLOOD PRESSURE DECREASED 21 0.0003
616 INFLUENZA LIKE ILLNESS 26 0.0003
617 INTENTIONAL DOSE OMISSION 9 0.0003
618 HAEMATEMESIS 8 0.0003
619 THROAT IRRITATION 14 0.0003
620 VOMITING 146 0.0003
621 ASTHMA 35 0.0003
622 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
623 DEAFNESS 8 0.0003
624 GASTRITIS 8 0.0003
625 ORAL CANDIDIASIS 4 0.0003
626 PERICARDIAL EFFUSION 7 0.0003
627 UNDERDOSE 22 0.0003
628 COAGULOPATHY 5 0.0003
629 FUNGAL INFECTION 10 0.0003
630 MENINGITIS 2 0.0003
631 PRODUCT STORAGE ERROR 26 0.0003
632 EXTRA DOSE ADMINISTERED 12 0.0003
633 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
634 PULMONARY EMBOLISM 28 0.0003
635 ABNORMAL LOSS OF WEIGHT 2 0.0003
636 EYE MOVEMENT DISORDER 2 0.0003
637 TEMPERATURE INTOLERANCE 3 0.0003
638 DROOLING 2 0.0003
639 LYMPHOEDEMA 2 0.0003
640 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
641 OXYGEN SATURATION DECREASED 16 0.0003
642 DEVICE OCCLUSION 4 0.0003
643 RENAL PAIN 3 0.0003
644 DIZZINESS 140 0.0003
645 ARTHRITIS 22 0.0003
646 DISCOMFORT 17 0.0003
647 FEELING HOT 17 0.0003
648 DEEP VEIN THROMBOSIS 18 0.0003
649 PAIN 170 0.0003
650 ANOSMIA 4 0.0003
651 FLUID RETENTION 14 0.0003
652 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
653 CHOLELITHIASIS 9 0.0003
654 ASPIRATION 3 0.0003
655 EYE DISORDER 9 0.0003
656 MAJOR DEPRESSION 2 0.0003
657 DENTAL CARIES 3 0.0003
658 BLOOD GLUCOSE ABNORMAL 5 0.0003
659 INJURY 19 0.0003
660 GAIT INABILITY 9 0.0003
661 FEELING DRUNK 2 0.0003
662 DYSPNOEA 152 0.0003
663 ABDOMINAL DISCOMFORT 45 0.0003
664 OCULAR DISCOMFORT 3 0.0003
665 HEPATIC CIRRHOSIS 5 0.0003
666 REBOUND EFFECT 3 0.0003
667 MUSCULAR WEAKNESS 30 0.0003
668 CHOLECYSTECTOMY 3 0.0003
669 INTERNAL HAEMORRHAGE 3 0.0003
670 SLEEP APNOEA SYNDROME 5 0.0003
671 HYPERTHERMIA 2 0.0003
672 BOWEL MOVEMENT IRREGULARITY 2 0.0003
673 SKIN DISCOLOURATION 12 0.0003
674 PRODUCT DOSE OMISSION 17 0.0003
675 THYROID DISORDER 4 0.0003
676 MUSCULOSKELETAL CHEST PAIN 4 0.0003
677 RASH PRURITIC 14 0.0003
678 PALPITATIONS 30 0.0003
679 SPLENOMEGALY 3 0.0003
680 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
681 MEMORY IMPAIRMENT 35 0.0003
682 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
683 RESPIRATORY DISTRESS 7 0.0003
684 COUGH 71 0.0003
685 PROCEDURAL PAIN 7 0.0003
686 ABSCESS 4 0.0003
687 BACK PAIN 58 0.0002
688 BLOOD DISORDER 2 0.0002
689 EYE PAIN 14 0.0002
690 SPEECH DISORDER 13 0.0002
691 CEREBROVASCULAR ACCIDENT 42 0.0002
692 NO THERAPEUTIC RESPONSE 3 0.0002
693 INJURY ASSOCIATED WITH DEVICE 5 0.0002
694 MUSCLE SPASMS 45 0.0002
695 BODY TEMPERATURE INCREASED 5 0.0002
696 INJECTION SITE EXTRAVASATION 3 0.0002
697 ABNORMAL WEIGHT GAIN 3 0.0002
698 LIVER FUNCTION TEST ABNORMAL 7 0.0002
699 HEMIPLEGIA 2 0.0002
700 HEMIPARESIS 4 0.0002
701 RENAL DISORDER 11 0.0002
702 IRRITABLE BOWEL SYNDROME 5 0.0002
703 CARDIAC OPERATION 2 0.0002
704 SKIN CANCER 5 0.0002
705 JOINT SWELLING 28 0.0002
706 RASH ERYTHEMATOUS 11 0.0002
707 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 0.0002
708 NAUSEA 182 0.0002
709 RASH MACULAR 8 0.0002
710 PYREXIA 79 0.0002
711 INCORRECT PRODUCT STORAGE 3 0.0002
712 DISORIENTATION 9 0.0002
713 APPLICATION SITE PAIN 5 0.0002
714 SNEEZING 5 0.0002
715 ADVERSE DRUG REACTION 20 0.0002
716 SINUS CONGESTION 3 0.0002
717 ANXIETY 63 0.0002
718 FEELING ABNORMAL 53 0.0002
719 FATIGUE 172 0.0002
720 HEPATIC ENZYME INCREASED 15 0.0002
721 GINGIVAL BLEEDING 3 0.0002
722 HYPOTHYROIDISM 7 0.0002
723 CELLULITIS 11 0.0002
724 ORAL DISCOMFORT 3 0.0002
725 DEMENTIA 6 0.0002
726 FLANK PAIN 2 0.0002
727 ASTHENIA 80 0.0002
728 PAIN IN JAW 6 0.0002
729 BLOOD PRESSURE FLUCTUATION 5 0.0002
730 DRUG PRESCRIBING ERROR 4 0.0002
731 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
732 MYOCARDIAL INFARCTION 36 0.0002
733 MENTAL IMPAIRMENT 5 0.0002
734 EAR PAIN 4 0.0002
735 ORAL HERPES 4 0.0002
736 INFLAMMATORY BOWEL DISEASE 2 0.0002
737 PRURITUS 78 0.0002
738 LIVER DISORDER 9 0.0002
739 OEDEMA 11 0.0002
740 HOSPICE CARE 2 0.0002
741 THERAPY NON-RESPONDER 9 0.0002
742 HEART RATE DECREASED 7 0.0002
743 HYPOAESTHESIA ORAL 3 0.0002
744 EMPHYSEMA 2 0.0002
745 THERAPEUTIC RESPONSE DECREASED 12 0.0002
746 ABDOMINAL PAIN LOWER 5 0.0002
747 EUPHORIC MOOD 2 0.0002
748 INITIAL INSOMNIA 2 0.0002
749 LUNG NEOPLASM MALIGNANT 8 0.0002
750 BASAL CELL CARCINOMA 3 0.0002
751 DIARRHOEA 123 0.0002
752 INCONTINENCE 2 0.0002
753 PNEUMOTHORAX 3 0.0002
754 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
755 RASH 82 0.0002
756 INJECTION SITE HAEMORRHAGE 15 0.0002
757 RETCHING 4 0.0002
758 NASAL CONGESTION 11 0.0002
759 HYPOAESTHESIA 28 0.0002
760 MENSTRUATION IRREGULAR 5 0.0002
761 WHEEZING 11 0.0002
762 MUSCLE TIGHTNESS 3 0.0002
763 FREQUENT BOWEL MOVEMENTS 5 0.0002
764 ATRIAL FIBRILLATION 18 0.0002
765 MENSTRUATION DELAYED 2 0.0002
766 SOMNOLENCE 37 0.0002
767 PALLOR 5 0.0002
768 DIABETES MELLITUS 14 0.0002
769 MOOD ALTERED 5 0.0002
770 MULTIPLE FRACTURES 3 0.0002
771 RESPIRATORY ARREST 5 0.0002
772 ABNORMAL DREAMS 5 0.0002
773 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
774 OEDEMA PERIPHERAL 22 0.0002
775 FOOT DEFORMITY 2 0.0002
776 CHILLS 21 0.0002
777 DYSPHAGIA 17 0.0002
778 PULMONARY OEDEMA 8 0.0002
779 PERICARDITIS 3 0.0002
780 INTESTINAL PERFORATION 2 0.0002
781 BLISTER 10 0.0002
782 HEART RATE IRREGULAR 4 0.0002
783 MYALGIA 30 0.0002
784 CIRCULATORY COLLAPSE 3 0.0002
785 ERYTHEMA 36 0.0002
786 TREMOR 29 0.0002
787 CONSTIPATION 38 0.0002
788 LETHARGY 10 0.0002
789 ELECTROLYTE IMBALANCE 2 0.0002
790 AMENORRHOEA 3 0.0002
791 CHOLECYSTITIS 2 0.0002
792 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
793 PRODUCTIVE COUGH 8 0.0002
794 MACULAR DEGENERATION 2 0.0002
795 HEPATIC CANCER 4 0.0002
796 LACRIMATION INCREASED 5 0.0002
797 HYPERTENSION 35 0.0002
798 LUNG DISORDER 8 0.0002
799 HAEMATOCHEZIA 9 0.0002
800 DYSURIA 6 0.0002
801 DRUG ADMINISTRATION ERROR 5 0.0002
802 CARDIOMEGALY 2 0.0002
803 GENERALISED OEDEMA 2 0.0002
804 NECK PAIN 9 0.0002
805 AGEUSIA 4 0.0002
806 PAIN IN EXTREMITY 47 0.0002
807 DYSPNOEA EXERTIONAL 6 0.0002
808 FLATULENCE 9 0.0002
809 FRACTURE 3 0.0002
810 TACHYCARDIA 14 0.0002
811 FEELING JITTERY 3 0.0002
812 HEPATITIS 4 0.0002
813 MYDRIASIS 2 0.0002
814 SLEEP DISORDER 11 0.0002
815 DRUG RESISTANCE 4 0.0002
816 HIP FRACTURE 5 0.0002
817 RASH GENERALISED 4 0.0002
818 INJECTION SITE INDURATION 2 0.0002
819 DEPRESSION 35 0.0002
820 HAEMORRHOIDS 3 0.0002
821 CHOKING 3 0.0002
822 INCORRECT DOSE ADMINISTERED 35 0.0002
823 NERVOUSNESS 8 0.0002
824 VISION BLURRED 21 0.0002
825 SKIN DISORDER 5 0.0001
826 EYE HAEMORRHAGE 2 0.0001
827 FEAR 4 0.0001
828 PRODUCT PHYSICAL ISSUE 3 0.0001
829 INTENTIONAL PRODUCT MISUSE 13 0.0001
830 PRODUCT QUALITY ISSUE 20 0.0001
831 COMA 7 0.0001
832 ARTHRALGIA 61 0.0001
833 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
834 PULMONARY HYPERTENSION 3 0.0001
835 POLLAKIURIA 6 0.0001
836 LYMPHADENOPATHY 5 0.0001
837 EATING DISORDER 3 0.0001
838 IMPAIRED WORK ABILITY 3 0.0001
839 BRONCHOSPASM 2 0.0001
840 LIVER FUNCTION TEST INCREASED 3 0.0001
841 CEREBRAL HAEMORRHAGE 5 0.0001
842 RECTAL HAEMORRHAGE 6 0.0001
843 IMPAIRED QUALITY OF LIFE 2 0.0001
844 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
845 ACCIDENTAL UNDERDOSE 2 0.0001
846 PRODUCT SUBSTITUTION ISSUE 8 0.0001
847 PRURITUS GENERALISED 3 0.0001
848 FAECES DISCOLOURED 3 0.0001
849 AMNESIA 9 0.0001
850 VAGINAL HAEMORRHAGE 6 0.0001
851 HYPERTHYROIDISM 2 0.0001
852 DEATH 119 0.0001
853 HAEMOGLOBIN DECREASED 14 0.0001
854 GAIT DISTURBANCE 26 0.0001
855 CARDIOMYOPATHY 2 0.0001
856 COLON CANCER 2 0.0001
857 ORAL PAIN 3 0.0001
858 RASH PAPULAR 3 0.0001
859 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
860 PANCREATITIS ACUTE 3 0.0001
861 IRRITABILITY 8 0.0001
862 APHASIA 4 0.0001
863 EPILEPSY 4 0.0001
864 FEMUR FRACTURE 4 0.0001
865 MENINGIOMA 2 0.0001
866 DRUG DOSE OMISSION 21 0.0001
867 MOOD SWINGS 4 0.0001
868 DECREASED APPETITE 29 0.0001
869 EMOTIONAL DISTRESS 15 0.0001
870 RHINORRHOEA 8 0.0001
871 BLOOD POTASSIUM INCREASED 2 0.0001
872 BLINDNESS 5 0.0001
873 DYSPEPSIA 12 0.0001
874 IMPAIRED HEALING 4 0.0001
875 OSTEOPOROSIS 5 0.0001
876 VISUAL IMPAIRMENT 15 0.0001
877 DRY EYE 6 0.0001
878 INSOMNIA 32 0.0001
879 CARDIO-RESPIRATORY ARREST 5 0.0001
880 WITHDRAWAL SYNDROME 5 0.0001
881 EYE PRURITUS 4 0.0001
882 CANDIDA INFECTION 2 0.0001
883 ALOPECIA 23 0.0001
884 HAEMATOMA 3 0.0001
885 NEUROPATHY PERIPHERAL 11 0.0001
886 DIPLOPIA 3 0.0001
887 DEVICE USE ISSUE 2 0.0001
888 PAIN OF SKIN 3 0.0001
889 RESPIRATORY FAILURE 8 0.0001
890 SKIN IRRITATION 5 0.0001
891 PARAESTHESIA 17 0.0001
892 MENTAL STATUS CHANGES 3 0.0001
893 FEELING COLD 3 0.0001
894 BREAST CANCER 10 0.0001
895 BLOOD CHOLESTEROL INCREASED 5 0.0001
896 DYSARTHRIA 4 0.0001
897 BLOOD SODIUM DECREASED 2 0.0001
898 ARRHYTHMIA 5 0.0001
899 BLOOD URINE PRESENT 2 0.0001
900 ACUTE RESPIRATORY FAILURE 2 0.0001
901 ERUCTATION 2 0.0001
902 MUSCULOSKELETAL STIFFNESS 9 0.0001
903 PLASMA CELL MYELOMA 4 0.0001
904 MENORRHAGIA 2 0.0001
905 ACUTE MYOCARDIAL INFARCTION 3 0.0001
906 URINARY INCONTINENCE 3 0.0001
907 DISABILITY 2 0.0001
908 AGGRESSION 5 0.0001
909 DEVICE MALFUNCTION 7 0.0001
910 CARDIAC FAILURE CONGESTIVE 8 0.0001
911 HEPATIC FAILURE 3 0.0001
912 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
913 FULL BLOOD COUNT DECREASED 2 0.0001
914 OVERDOSE 21 0.0001
915 EMOTIONAL DISORDER 3 0.0001
916 RHEUMATOID ARTHRITIS 11 0.0001
917 AGITATION 7 0.0001
918 MOUTH ULCERATION 2 0.0001
919 HYPERHIDROSIS 12 0.0001
920 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
922 FLUSHING 9 0.0001
923 TINNITUS 4 0.0001
924 MUSCLE TWITCHING 2 0.0001
925 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
926 BONE PAIN 5 0.0001
927 TREATMENT FAILURE 7 0.0001
928 DISEASE RECURRENCE 4 0.0001
929 SKIN BURNING SENSATION 6 0.0001
930 RENAL IMPAIRMENT 7 0.0001
931 SKIN EXFOLIATION 7 0.0001
932 STOMATITIS 5 0.0001
933 PLEURAL EFFUSION 5 0.0001
934 DRUG INTERACTION 13 0.0001
935 CEREBRAL INFARCTION 2 0.0001
936 ENCEPHALOPATHY 2 0.0001
937 BALANCE DISORDER 7 0.0001
938 EPISTAXIS 6 0.0001
939 HYPOTENSION 16 0.0001
940 HYPOPHAGIA 2 0.0001
941 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
942 MUSCULOSKELETAL PAIN 4 0.0001
943 BREAST CANCER FEMALE 2 0.0001
944 JAUNDICE 2 0.0001
945 DISTURBANCE IN ATTENTION 4 0.0001
946 DRY MOUTH 6 0.0001
947 DEVICE BREAKAGE 3 0.0001
948 COMPLETED SUICIDE 6 0.0001
949 HAEMOPTYSIS 2 0.0001
950 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
951 OSTEOARTHRITIS 3 0.0001
952 HYPERSOMNIA 2 0.0001
953 DEVICE LEAKAGE 3 0.0001
954 DYSSTASIA 2 0.0001
955 HOT FLUSH 5 0.0001
956 HYPOKALAEMIA 3 0.0001
957 COGNITIVE DISORDER 3 0.0001
958 DRUG-INDUCED LIVER INJURY 2 0.0001
959 RENAL CANCER 3 0.0001
960 ANAEMIA 12 0.0001
961 MULTIPLE SCLEROSIS 3 0.0001
962 DRUG INTOLERANCE 6 0.0001
963 INTERSTITIAL LUNG DISEASE 3 0.0001
964 CONFUSIONAL STATE 10 0.0001
965 HYPOGLYCAEMIA 3 0.0001
966 BLOOD CREATININE INCREASED 4 0.0001
967 CARDIAC ARREST 5 0.0001
968 RENAL FAILURE 8 0.0001
969 HAEMATURIA 2 0.0001
970 DELIRIUM 2 0.0001
971 ECZEMA 3 0.0001
972 HYPOXIA 2 0.0001
973 MOBILITY DECREASED 4 0.0001
974 MEDICATION ERROR 3 0.0001
975 CONVULSION 3 0.0001
976 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
977 CARDIAC FAILURE 4 0.0000
978 PROSTATE CANCER 4 0.0000
979 DYSKINESIA 2 0.0000
980 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
981 HYPOACUSIS 2 0.0000
982 LEUKOPENIA 2 0.0000
983 PSORIASIS 5 0.0000
984 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
985 BLOOD GLUCOSE INCREASED 7 0.0000
986 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
987 SUICIDAL IDEATION 3 0.0000
988 INTENTIONAL OVERDOSE 2 0.0000
989 DEVICE DIFFICULT TO USE 2 0.0000
990 DRUG DEPENDENCE 3 0.0000
991 DRY SKIN 2 0.0000